135 related articles for article (PubMed ID: 38614269)
1. C-reactive protein (CRP) as a prognostic biomarker in patients with urothelial carcinoma: A systematic review and meta-analysis.
Fujiwara Y; Karol AB; Joshi H; Reford E; Izadmehr S; Doroshow DB; Galsky MD
Crit Rev Oncol Hematol; 2024 May; 197():104352. PubMed ID: 38614269
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
[TBL] [Abstract][Full Text] [Related]
3. Association Between Serum Magnesium Levels and Outcomes of Atezolizumab in Patients With Metastatic Urothelial Carcinoma.
Fukuokaya W; Akazawa K; Kimura T
Anticancer Res; 2024 May; 44(5):2117-2123. PubMed ID: 38677745
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma.
Klümper N; Sikic D; Saal J; Büttner T; Goldschmidt F; Jarczyk J; Becker P; Zeuschner P; Weinke M; Kalogirou C; Breyer J; Burger M; Nuhn P; Tully K; Roghmann F; Bolenz C; Zengerling F; Wirtz RM; Muders M; Kristiansen G; Bald T; Ellinger J; Wullich B; Hölzel M; Hartmann A; Erben P; Ritter M; Eckstein M
Eur J Cancer; 2022 May; 167():13-22. PubMed ID: 35366569
[TBL] [Abstract][Full Text] [Related]
5. The evaluation of monocyte lymphocyte ratio as a preoperative predictor in urothelial malignancies: a pooled analysis based on comparative studies.
Zhu X; Wu SQ; Xu R; Wang YH; Zhong ZH; Zhang L; Zhao XK
Sci Rep; 2019 Apr; 9(1):6280. PubMed ID: 31000754
[TBL] [Abstract][Full Text] [Related]
6. Impact of Routine Laboratory Parameters in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Long-Term Follow-Up.
Tamalunas A; Buchner A; Kretschmer A; Jokisch F; Schulz G; Eismann L; Stief CG; Grimm T
Urol Int; 2020; 104(7-8):551-558. PubMed ID: 32114587
[TBL] [Abstract][Full Text] [Related]
7. Differential Effect of Sex on Outcomes after Radical Surgery for Upper Tract and Bladder Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
Mori K; Mostafaei H; Enikeev DV; Lysenko I; Quhal F; Kimura S; Karakiewicz PI; Egawa S; Shariat SF
J Urol; 2020 Jul; 204(1):58-62. PubMed ID: 31995432
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of circulating cytokines and inflammation indexes for avelumab maintenance in metastatic urothelial carcinoma.
Maiorano BA; Schinzari G; Carbone C; Piro G; Rossi E; Di Maio M; Di Giacomo A; Maiello E
Front Immunol; 2024; 15():1401214. PubMed ID: 38799450
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis.
Dai J; Tang K; Xiao W; Yu G; Zeng J; Li W; Zhang YQ; Xu H; Chen ZQ; Ye ZQ
Asian Pac J Cancer Prev; 2014; 15(8):3369-75. PubMed ID: 24870724
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Role of C-Reactive Protein In Urological Cancers: A Meta-Analysis.
Zhou L; Cai X; Liu Q; Jian ZY; Li H; Wang KJ
Sci Rep; 2015 Aug; 5():12733. PubMed ID: 26235332
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Metastatic Urothelial Carcinoma Patients Treated With First-line Chemotherapy: A Large Multicenter Study.
Auvray M; Elaidi R; Ozguroglu M; Guven S; Gauthier H; Culine S; Caty A; Dujardin C; Auclin E; Thibaut C; Combe P; Tartour E; Oudard S
Clin Genitourin Cancer; 2017 Jun; 15(3):e469-e476. PubMed ID: 27964892
[TBL] [Abstract][Full Text] [Related]
12. Serum C-reactive protein: a prognostic factor in metastatic urothelial cancer of the bladder.
Eggers H; Seidel C; Schrader AJ; Lehmann R; Wegener G; Kuczyk MA; Steffens S
Med Oncol; 2013 Dec; 30(4):705. PubMed ID: 24005810
[TBL] [Abstract][Full Text] [Related]
13. The preoperative serum cystatin-C as an independent prognostic factor for survival in upper tract urothelial carcinoma.
Tan P; Shi M; Chen J; Xu H; Xie N; Xu H; Jiang Y; Ai JZ; Liu LR; Yang L; Wei Q
Asian J Androl; 2019; 21(2):163-169. PubMed ID: 30416134
[TBL] [Abstract][Full Text] [Related]
14. Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer.
Cantiello F; Russo GI; Vartolomei MD; Farhan ARA; Terracciano D; Musi G; Lucarelli G; Di Stasi SM; Hurle R; Serretta V; Busetto GM; Scafuro C; Perdonà S; Borghesi M; Schiavina R; Cioffi A; De Berardinis E; Almeida GL; Bove P; Lima E; Ucciero G; Matei DV; Crisan N; Verze P; Battaglia M; Guazzoni G; Autorino R; Morgia G; Damiano R; de Cobelli O; Mirone V; Shariat SF; Ferro M
Eur Urol Oncol; 2018 Oct; 1(5):403-410. PubMed ID: 31158079
[TBL] [Abstract][Full Text] [Related]
15. Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab.
Kijima T; Yamamoto H; Saito K; Kusuhara S; Yoshida S; Yokoyama M; Matsuoka Y; Numao N; Sakai Y; Matsubara N; Yuasa T; Masuda H; Yonese J; Kageyama Y; Fujii Y
Cancer Immunol Immunother; 2021 Mar; 70(3):657-665. PubMed ID: 32876736
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis.
Mori K; Miura N; Mostafaei H; Quhal F; Motlagh RS; Lysenko I; Kimura S; Egawa S; Karakiewicz PI; Shariat SF
Int J Clin Oncol; 2020 Aug; 25(8):1459-1474. PubMed ID: 32451768
[TBL] [Abstract][Full Text] [Related]
17. Pre-first-line chemotherapy risk stratification for overall survival in advanced urothelial carcinoma in sequential therapy era.
Shindo T; Hashimoto K; Fujino K; Takahashi A; Hotta H; Maeda T; Kunishima Y; Fukuta F; Ito N; Wanifuchi A; Kato R; Okada M; Matsukawa M; Horita H; Takayanagi A; Kobayashi K; Tanaka T; Masumori N
World J Urol; 2024 May; 42(1):307. PubMed ID: 38722418
[TBL] [Abstract][Full Text] [Related]
18. Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes.
Saito K; Kihara K
Int J Urol; 2013 Feb; 20(2):161-71. PubMed ID: 22897628
[TBL] [Abstract][Full Text] [Related]
19. The impact of postoperative inflammatory biomarkers on oncologic outcomes of bladder cancer.
Albisinni S; Moussa I; Aoun F; Quackels T; Assenmacher G; Peltier A; Roumeguère T
Prog Urol; 2019 Apr; 29(5):270-281. PubMed ID: 30954405
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of preoperative blood-based biomarkers in upper tract urothelial carcinoma treated with nephroureterectomy: A systematic review and meta-analysis.
Mori K; Janisch F; Mostafaei H; Lysenko I; Kimura S; Egawa S; Shariat SF
Urol Oncol; 2020 May; 38(5):315-333. PubMed ID: 32088103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
